Stefania Morganti

Also affiliated with Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Clonal Hematopoiesis Dynamics and Evolutionary Fitness During Cancer Treatment Impact Clinical Outcomes”.

Clonal Hematopoiesis Dynamics and Evolutionary Fitness During Cancer Treatment Impact Clinical Outcomes

medRxiv(2025)10.1101/2025.08.27.25334581

N/A

0DataRank · unranked

2 citations

Yi-Han Tang, Christelle Colin, Sadegh Marzban, Daniel Walgenbach, Stefania Morganti +12 more

A Randomized Phase 2 Study of Neratinib With or Without Fulvestrant for Patients With HER2-Positive, Estrogen Receptor-Positive Metastatic Breast Cancer

Clinical Breast Cancer(2025)10.1016/j.clbc.2025.05.009

N/A

0DataRank · unranked

0 citations

Xiangying Chu, Tarah J. Ballinger, Nisha Unni, Sarah Sinclair, Robert Wesolowski +9 more